Bio-FD&C Co. Ltd.
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soot… Read more
Bio-FD&C Co. Ltd. (251120) - Total Assets
Latest total assets as of September 2025: ₩72.27 Billion KRW
Based on the latest financial reports, Bio-FD&C Co. Ltd. (251120) holds total assets worth ₩72.27 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bio-FD&C Co. Ltd. - Total Assets Trend (2018–2024)
This chart illustrates how Bio-FD&C Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bio-FD&C Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Bio-FD&C Co. Ltd.'s total assets of ₩72.27 Billion consist of 75.5% current assets and 24.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩7.66 Billion | 11.4% |
| Accounts Receivable | ₩979.82 Million | 1.5% |
| Inventory | ₩2.02 Billion | 3.0% |
| Property, Plant & Equipment | ₩13.64 Billion | 20.3% |
| Intangible Assets | ₩344.29 Million | 0.5% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Bio-FD&C Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bio-FD&C Co. Ltd.'s current assets represent 75.5% of total assets in 2024, an increase from 41.1% in 2018.
- Cash Position: Cash and equivalents constituted 11.4% of total assets in 2024, down from 17.6% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2018.
- Asset Diversification: The largest asset category is property, plant & equipment at 20.3% of total assets.
Bio-FD&C Co. Ltd. Competitors by Total Assets
Key competitors of Bio-FD&C Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Bio-FD&C Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Bio-FD&C Co. Ltd. generates 0.24x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Bio-FD&C Co. Ltd. generates $6.69 in net profit.
Bio-FD&C Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 16.08 | 12.28 | 1.25 |
| Quick Ratio | 15.46 | 11.72 | 0.99 |
| Cash Ratio | 0.00 | 2.14 | 0.57 |
| Working Capital | ₩53.37 Billion | ₩ 44.90 Billion | ₩ 1.31 Billion |
Bio-FD&C Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Bio-FD&C Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.93 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.2% |
| Total Assets | ₩67.32 Billion |
| Market Capitalization | $48.22 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bio-FD&C Co. Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bio-FD&C Co. Ltd.'s assets grew by 7.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bio-FD&C Co. Ltd. (2018–2024)
The table below shows the annual total assets of Bio-FD&C Co. Ltd. from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩67.32 Billion | +7.17% |
| 2023-12-31 | ₩62.81 Billion | +6.40% |
| 2022-12-31 | ₩59.04 Billion | +156.23% |
| 2021-12-31 | ₩23.04 Billion | +30.71% |
| 2020-12-31 | ₩17.63 Billion | +15.27% |
| 2019-12-31 | ₩15.29 Billion | +23.24% |
| 2018-12-31 | ₩12.41 Billion | -- |